查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1830892

2025年全球性行為感染感染（STI）及陰道炎聚合酵素鏈鎖反應（PCR）檢測市場報告

Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，性行為感染感染（STI）和陰道炎聚合酵素鏈鎖反應（PCR）檢測市場迅速擴張，預計從2024年的6.2億美元成長到2025年的6.8億美元，複合年成長率達10.1%。這一成長主要歸功於遠端醫療平台的擴張、電子健康記錄的日益普及、保險覆蓋範圍的擴大、社區檢測舉措的增加以及診斷檢測數量的成長。

預計未來幾年，性行為感染感染 (STI) 和陰道炎聚合酵素鏈鎖反應(PCR) 檢測市場將保持強勁成長，到 2029 年市場規模將達到 9.9 億美元，複合年成長率 (CAGR) 為 9.8%。預測期內的成長主要歸因於全球性行為感染盛行率的上升、陰道感染疾病發生率的增加、育齡人口的成長以及整體人口的成長。預測期內的關鍵趨勢包括技術進步、多重 PCR 檢測板的應用、與遠端醫療平台的整合、與數位設備的連接以及自採樣檢測套組的開發。

性行為感染感染（STI）和陰道炎的聚合酵素鏈鎖反應（PCR）檢測是一種高度精確的分子診斷技術，它能夠擴增和檢測引起性行為感染和陰道感染疾病的病原體的遺傳物質。此方法可快速識別細菌、病毒和其他微生物，使醫療保健人員能夠有效診斷感染疾病並制定個人化治療方法。

性傳染感染和陰道炎PCR檢測的主要類型包括性傳染感染PCR檢測組合和陰道炎PCR檢測組合。性傳染感染是由細菌、病毒、真菌或寄生蟲引起的感染疾病，主要透過性接觸傳播，包括陰道性交、肛交和口交。這些檢測涵蓋多種性行為感染感染和陰道感染疾病，並被包括醫院/診所、診斷實驗室和家庭護理/居家檢測在內的各種終端使用者使用。

美國不斷提高的關稅以及持續到2025年的貿易緊張局勢正對醫療設備行業產生重大影響，尤其是進口診斷成像設備部件、手術用不銹鋼和塑膠耗材。醫院和診所都在抵制價格上漲，這擠壓了製造商的淨利率。監管障礙加劇了這個問題，因為與關稅相關的供應商變更通常需要重新認證設備，從而延緩產品上市時間。企業正透過關鍵零件的雙重採購、擴大國內同質化產品的生產以及加速研發經濟高效材料來降低風險。

本研究報告為商業研究公司（The Business Research Company）最新系列報告的一部分，該系列報告提供性行為感染感染（STI）和性行為感染聚合酵素鏈鎖反應聚合酵素鏈鎖反應（PCR）檢測行業的市場統計數據，包括全球市場規模、區域佔有率、性傳播感染（STI）和陰道炎聚合酵素鏈鎖反應（性行為感染（STI）和陰道炎聚合酶鏈反應（PCR）本市場研究報告對該行業的現狀和未來發展趨勢進行了詳細分析，為您提供所需的一切全面觀點。

預計未來幾年，性健康檢測的增加將推動性行為感染感染 (STI) 和陰道炎聚合酵素鏈鎖反應(PCR) 檢測市場的成長。性健康檢測包括用於檢測性傳染感染及相關疾病的醫學檢測，從而實現早期診斷、治療和預防疾病傳播。篩檢檢測的增加正值全球性傳染感染盛行率不斷上升之際，凸顯了及時檢測和治療對於預防併發症和遏制感染傳播的重要性。這些篩檢檢測對於性傳染感染和陰道炎 PCR 檢測至關重要，能夠早期準確地識別感染，即使是無症狀感染者也能被識別，從而支持及時治療和感染控制。例如，根據英國英國安全局的數據，2023年6月共進行了2,195,909次披衣菌感染、淋病、梅毒或愛滋病毒的性健康篩檢服務，比2021年的1,936,455次增加了13.4%。因此，性健康檢測的增加正在推動性傳染感染和陰道炎PCR檢測市場的成長。

性傳染感染和陰道炎PCR檢測市場的關鍵參與者正在率先開發創新解決方案，例如多重PCR檢測，以提高診斷準確性、縮短檢測時間並加快治療決策。多重PCR檢測是一種診斷工具，它利用單次PCR反應即可從單一樣本同時檢測多種病原體。例如，2022年11月，美國分子診斷公司Cepheid Inc.推出了Xpert Xpress多重陰道病原體檢測板（MVP）。這種快速多重PCR檢測可從單一陰道樣本中檢測出三種主要陰道感染病原體—細菌性陰道炎、外陰陰道念珠菌症和滴蟲病—的DNA。此檢測可在約60分鐘內提供結果，有助於對有症狀的女性進行更快、更準確的診斷，並有助於標靶治療，從而減少治療失敗和不必要的抗生素使用。此檢測與Cepheid的GeneXpert系統相容，可透過在照護端快速識別併發感染疾病，從而改善臨床決策和患者預後。

2022年6月，總部位於德國的檢測解決方案開發商R-Biopharm Inc.收購了AusDiagnostics，具體金額未揭露。透過此次收購，R-Biopharm旨在拓展其分子診斷能力，豐富其臨床診斷產品組合，進軍新的全球市場領域，並鞏固其作為值得信賴的系統解決方案提供者的地位，提供更完善的診斷方案。總部位於澳洲的AusDiagnostics生產用於分子診斷症候群檢測的體外診斷劑和機器人系統，並提供性傳播感染和陰道炎的PCR檢測。

性行為感染感染 (STI) 和陰道炎聚合酵素鏈鎖反應(PCR) 檢測市場由提供臨床諮詢、綜合篩檢、多重檢測、治療監測和檢體採集指導等服務的營業單位所獲得的收入構成。市場價值還包括服務提供者銷售的或包含在其服務中的相關產品的價值。性行為感染感染 (STI) 和陰道炎聚合酵素鏈鎖反應(PCR) 檢測市場還包括核酸萃取試劑套件、陽性和陰性對照、自動化 PCR 分析儀以及單病原體 PCR檢測套組的銷售。該市場的價值為“出廠價”，即產品製造商或創建者銷售的產品價值，無論銷售對像是其他營業單位（包括下游製造商、經銷商、分銷商和零售商）還是直接銷售給最終客戶。該市場的產品價值還包括產品創建者銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅，以及新冠疫情及其復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球性行為感染感染（STI）和陰道炎聚合酵素鏈鎖反應（PCR）檢測：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 終端用戶產業分析
  • 全球性行為感染（STI）和陰道炎聚合酵素鏈鎖反應（PCR）檢測市場：成長率分析
  • 全球性行為感染（STI）和陰道炎聚合酵素鏈鎖反應（PCR）檢測市場表現：規模和成長，2019-2024年
  • 全球性行為感染（STI）和陰道炎聚合酵素鏈鎖反應（PCR）檢測市場預測：規模和成長，2024-2029年，2034年
  • 全球性行為感染（STI）和陰道炎聚合酵素鏈鎖反應（PCR）檢測：潛在市場規模（TAM）

第6章 市場細分

  • 全球性行為感染（STI）和陰道炎聚合酵素鏈鎖反應（PCR）檢測市場：按檢測類型、表現和預測分類，2019-2024年、2024-2029年、2034年
  • 性行為感染感染（STI）聚合酵素鏈鎖反應（PCR）檢測組
  • 陰道炎聚合酵素鏈鎖反應（PCR）檢測組
  • 全球性行為感染（STI）和陰道炎聚合酵素鏈鎖反應（PCR）檢測市場：依病症、表現和預測分類，2019-2024年、2024-2029年、2034年
  • 性行為感染傳染病
  • 陰道感染疾病
  • 全球性行為感染（STI）和陰道炎聚合酵素鏈鎖反應（PCR）檢測市場：按最終用途、性能和預測分類，2019-2024年、2024-2029年、2034年
  • 醫院和診所
  • 診斷實驗室
  • 居家護理或居家檢測
  • 其他
  • 全球性行為感染感染（STI）和陰道炎聚合酵素鏈鎖反應（PCR）檢測市場：性行為感染感染（STI）聚合酵素鏈鎖反應（PCR）檢測板細分，按類型、性能和預測，2019-2024年、2024-2029年、2034年
  • 披衣菌感染衣原體聚合酵素鏈鎖反應
  • 淋病奈瑟聚合酵素鏈鎖反應
  • 陰道滴蟲炎聚合酵素鏈鎖反應
  • 單純皰疹病毒聚合酵素鏈鎖反應
  • 人類乳突病毒聚合酵素鏈鎖反應
  • 黴漿菌支原體聚合酵素鏈鎖反應
  • 梅毒聚合酵素鏈鎖反應
  • 多重性行為感染傳染病聚合酵素鏈鎖反應檢測組
  • 全球性行為感染(STI) 和陰道炎聚合酵素鏈鎖反應(PCR) 檢測市場：陰道炎聚合酵素鏈鎖反應(PCR) 檢測板細分，按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 細菌性陰道炎聚合酵素鏈鎖反應
  • 念珠菌聚合酵素鏈鎖反應
  • 滴蟲病聚合酵素鏈鎖反應
  • 混合型陰道炎聚合酵素鏈鎖反應檢測
  • 需氧性陰道炎聚合酵素鏈鎖反應
  • 萎縮性陰道炎聚合酵素鏈鎖反應

第7章 區域和國家分析

  • 全球性行為感染（STI）及陰道炎聚合酵素鏈鎖反應（PCR）檢測市場按地區分類、績效及預測（2019-2024年、2024-2029年、2034年）
  • 全球性行為感染（STI）及陰道炎聚合酵素鏈鎖反應（PCR）檢測市場依國家/地區分類、績效及預測（2019-2024年、2024-2029年、2034年）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章：俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 性行為感染感染（STI）和陰道炎聚合酵素鏈鎖反應（PCR）檢測市場：競爭格局
  • 性行為感染感染（STI）和陰道炎聚合酵素鏈鎖反應（PCR）檢測市場：公司概況
    • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Hologic Inc.
  • QIAGEN NV
  • ARUP Laboratories Inc.
  • Seegene Inc.
  • LetsGetChecked Ltd.
  • Sansure Biotech Inc.
  • Visby Medical Inc.
  • R-Biopharm AG
  • Savyon Diagnostics Ltd.
  • altona Diagnostics GmbH
  • SpeeDx Pty Ltd.
  • CERTEST BIOTEC SL
  • ALPCO Diagnostics
  • Atila Biosystems Inc.
  • Ridacom Diagnostics Ltd.

第32章 全球市場競爭基準化分析與儀錶板

第33章 重大併購

第34章 近期市場趨勢

第35章：高潛力市場國家、細分市場與策略

  • 2029年性行為感染感染（STI）和陰道炎聚合酵素鏈鎖反應（PCR）檢測市場：提供新機會的國家
  • 2029年性行為感染感染（STI）和陰道炎聚合酵素鏈鎖反應（PCR）檢測市場：提供新機會的細分市場
  • 2029年性行為感染感染（STI）和陰道炎聚合酵素鏈鎖反應（PCR）檢測市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章附錄

簡介目錄
Product Code: r37883

Sexually transmitted infection (STI) and vaginitis polymerase chain reaction (PCR) testing is a highly accurate molecular diagnostic technique that amplifies and detects the genetic material of pathogens responsible for sexually transmitted and vaginal infections. This method allows for rapid identification of bacteria, viruses, and other microorganisms, enabling healthcare providers to diagnose infections effectively and customize treatments.

The primary test types for STI and vaginitis PCR testing include STI PCR panels and vaginitis PCR panels. STIs are infections caused by bacteria, viruses, fungi, or parasites, primarily transmitted through sexual contact, including vaginal, anal, and oral sex. These tests cover a broad spectrum of sexually transmitted and vaginal infections and are used by various end users such as hospitals and clinics, diagnostic laboratories, and homecare or at-home testing services.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The sexually transmitted infection (STI) and vaginitis polymerase chain reaction (PCR) testing market research report is one of a series of new reports from The Business Research Company that provides sexually transmitted infection (STI) and vaginitis polymerase chain reaction (PCR) testing market statistics, including sexually transmitted infection (STI) and vaginitis polymerase chain reaction (PCR) testing industry global market size, regional shares, competitors with a sexually transmitted infection (STI) and vaginitis polymerase chain reaction (PCR) testing market share, detailed sexually transmitted infection (STI) and vaginitis polymerase chain reaction (PCR) testing market segments, market trends and opportunities, and any further data you may need to thrive in the sexually transmitted infection (STI) and vaginitis polymerase chain reaction (PCR) testing industry. This sexually transmitted infection (STI) and vaginitis polymerase chain reaction (PCR) testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The sexually transmitted infection (STI) and vaginitis polymerase chain reaction (PCR) testing market size has grown rapidly in recent years. It will grow from $0.62 billion in 2024 to $0.68 billion in 2025 at a compound annual growth rate (CAGR) of 10.1%. The growth in the historic period can be attributed to the expansion of telemedicine platforms, increased adoption of electronic health records, rising insurance coverage, growth in community-based testing initiatives, and a higher number of diagnostic tests being conducted.

The sexually transmitted infection (STI) and vaginitis polymerase chain reaction (PCR) testing market size is expected to see strong growth in the next few years. It will grow to $0.99 billion in 2029 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to the increasing global prevalence of sexually transmitted infections, rising incidence of vaginal infections, a growing population of reproductive-age individuals, and overall population growth. Major trends in the forecast period include technological advancements, adoption of multiplex PCR panels, integration with telehealth platforms, connectivity with digital devices, and the development of self-collected testing kits.

The increasing number of sexual health screenings is expected to drive growth in the sexually transmitted infection (STI) and vaginitis polymerase chain reaction (PCR) testing market in the coming years. Sexual health screenings involve medical tests that detect STIs and related conditions, enabling early diagnosis, treatment, and prevention of disease transmission. The rise in screenings is driven by the growing prevalence of STIs worldwide, highlighting the need for timely detection and treatment to prevent complications and limit the spread of infections. These screenings are critical for STI and vaginitis PCR testing, as they allow for early and accurate identification of infections, often even in asymptomatic individuals, supporting prompt treatment and infection control. For example, according to the UK Health Security Agency, a UK-based government body, 2,195,909 sexual health screening services for chlamydia, gonorrhea, syphilis, or HIV were conducted in June 2023, representing a 13.4% increase from the 1,936,455 tests performed in 2021. Consequently, the rise in sexual health screenings is fueling growth in the STI and vaginitis PCR testing market.

Key players in the STI and vaginitis PCR testing market are developing innovative solutions, such as multiplex PCR tests, to improve diagnostic accuracy, reduce testing time, and enable faster treatment decisions. Multiplex PCR tests are diagnostic tools that detect multiple pathogens simultaneously from a single sample using one PCR reaction. For instance, in November 2022, Cepheid Inc., a US-based molecular diagnostics company, launched the Xpert Xpress Multiplex Vaginal Panel (MVP), a rapid multiplex PCR test that detects DNA from the three primary causes of vaginal infections, bacterial vaginosis, vulvovaginal candidiasis, and trichomoniasis using a single vaginal sample. Delivering results in approximately 60 minutes, this test supports faster and more precise diagnosis in symptomatic women, facilitating targeted treatments that reduce treatment failures and unnecessary antibiotic use. Compatible with Cepheid's GeneXpert systems, it enhances clinical decision-making and patient outcomes by quickly identifying co-infections at the point of care.

In June 2022, R-Biopharm Inc., a Germany-based developer of test solutions, acquired AusDiagnostics for an undisclosed amount. Through this acquisition, R-Biopharm aims to expand its molecular diagnostics capabilities, broaden its clinical diagnostics portfolio, enter new global market segments, and strengthen its position as a trusted provider of system solutions with enhanced diagnostic options. AusDiagnostics, based in Australia, manufactures in vitro diagnostic reagents and robotic systems for molecular-based syndromic testing, offering PCR testing for STIs and vaginitis.

Major players in the sexually transmitted infection (STI) and vaginitis polymerase chain reaction (PCR) testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton Dickinson and Company, Hologic Inc., QIAGEN N.V., ARUP Laboratories Inc., Seegene Inc., LetsGetChecked Ltd., Sansure Biotech Inc., Visby Medical Inc., R-Biopharm AG, Savyon Diagnostics Ltd., altona Diagnostics GmbH, SpeeDx Pty Ltd., CERTEST BIOTEC S.L., ALPCO Diagnostics, Atila Biosystems Inc., Ridacom Diagnostics Ltd., Sinochips Diagnostics Co Ltd., Vitassay S.L., and Bioperfectus Technologies Co. Ltd.

North America was the largest region in the sexually transmitted infection (STI) and vaginitis polymerase chain reaction (PCR) testing market in 2024. The regions covered in sexually transmitted infection (STI) and vaginitis polymerase chain reaction (PCR) testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the sexually transmitted infection (STI) and vaginitis polymerase chain reaction (PCR) testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The sexually transmitted infection (STI) and vaginitis polymerase chain reaction (PCR) testing market consists of revenues earned by entities by providing services such as clinical consultations, comprehensive screening tests, multiplex testing, treatment monitoring, and sample collection guidance. The market value includes the value of related goods sold by the service provider or included within the service offering. The sexually transmitted infection (STI) and vaginitis polymerase chain reaction (PCR) testing market also includes sales of nucleic acid extraction kits, positive and negative control materials, automated PCR analyzers, and single-pathogen PCR test kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on sexually transmitted infection (sti) and vaginitis polymerase chain reaction (pcr) testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for sexually transmitted infection (sti) and vaginitis polymerase chain reaction (pcr) testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The sexually transmitted infection (sti) and vaginitis polymerase chain reaction (pcr) testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Test Type: Sexually Transmitted Infection (STR) Polymerase Chain Reaction (PCR) Panels; Vaginitis Polymerase Chain Reaction (PCR) Panels
  • 2) By Condition: Sexually Transmitted Infections; Vaginal Infections
  • 3) By End User: Hospitals And Clinics; Diagnostic Laboratories; Homecare Or At-Home Testing; Other End Users
  • Subsegments:
  • 1) By Sexually Transmitted Infection (STR) Polymerase Chain Reaction (PCR) Panels: Chlamydia Trachomatis Polymerase Chain Reaction; Neisseria Gonorrhoeae Polymerase Chain Reaction; Trichomonas Vaginalis Polymerase Chain Reaction; Herpes Simplex Virus Polymerase Chain Reaction; Human Papillomavirus Polymerase Chain Reaction; Mycoplasma Genitalium Polymerase Chain Reaction; Syphilis Polymerase Chain Reaction; Multiplex Sexually Transmitted Infection Polymerase Chain Reaction Panels
  • 2) By Vaginitis Polymerase Chain Reaction (PCR) Panels: Bacterial Vaginosis Polymerase Chain Reaction; Candida Species Polymerase Chain Reaction; Trichomoniasis Polymerase Chain Reaction; Mixed Vaginitis Polymerase Chain Reaction Panels; Aerobic Vaginitis Polymerase Chain Reaction; Atrophic Vaginitis Polymerase Chain Reaction
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Becton Dickinson and Company; Hologic Inc.; QIAGEN N.V.; ARUP Laboratories Inc.; Seegene Inc.; LetsGetChecked Ltd.; Sansure Biotech Inc.; Visby Medical Inc.; R-Biopharm AG; Savyon Diagnostics Ltd.; altona Diagnostics GmbH; SpeeDx Pty Ltd.; CERTEST BIOTEC S.L.; ALPCO Diagnostics; Atila Biosystems Inc.; Ridacom Diagnostics Ltd.; Sinochips Diagnostics Co Ltd.; Vitassay S.L.; Bioperfectus Technologies Co. Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Characteristics

3. Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Trends And Strategies

4. Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Growth Rate Analysis
  • 5.4. Global Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Total Addressable Market (TAM)

6. Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Segmentation

  • 6.1. Global Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Sexually Transmitted Infection (STR) Polymerase Chain Reaction (PCR) Panels
  • Vaginitis Polymerase Chain Reaction (PCR) Panels
  • 6.2. Global Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Sexually Transmitted Infections
  • Vaginal Infections
  • 6.3. Global Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Clinics
  • Diagnostic Laboratories
  • Homecare Or At-Home Testing
  • Other End Users
  • 6.4. Global Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Sub-Segmentation Of Sexually Transmitted Infection (STR) Polymerase Chain Reaction (PCR) Panels, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Chlamydia Trachomatis Polymerase Chain Reaction
  • Neisseria Gonorrhoeae Polymerase Chain Reaction
  • Trichomonas Vaginalis Polymerase Chain Reaction
  • Herpes Simplex Virus Polymerase Chain Reaction
  • Human Papillomavirus Polymerase Chain Reaction
  • Mycoplasma Genitalium Polymerase Chain Reaction
  • Syphilis Polymerase Chain Reaction
  • Multiplex Sexually Transmitted Infection Polymerase Chain Reaction Panels
  • 6.5. Global Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Sub-Segmentation Of Vaginitis Polymerase Chain Reaction (PCR) Panels, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bacterial Vaginosis Polymerase Chain Reaction
  • Candida Species Polymerase Chain Reaction
  • Trichomoniasis Polymerase Chain Reaction
  • Mixed Vaginitis Polymerase Chain Reaction Panels
  • Aerobic Vaginitis Polymerase Chain Reaction
  • Atrophic Vaginitis Polymerase Chain Reaction

7. Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Regional And Country Analysis

  • 7.1. Global Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 8.1. Asia-Pacific Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 9.1. China Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Overview
  • 9.2. China Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 10.1. India Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 11.1. Japan Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Overview
  • 11.2. Japan Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 12.1. Australia Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 13.1. Indonesia Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 14.1. South Korea Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Overview
  • 14.2. South Korea Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 15.1. Western Europe Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Overview
  • 15.2. Western Europe Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 16.1. UK Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 17.1. Germany Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 18.1. France Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 19.1. Italy Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 20.1. Spain Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 21.1. Eastern Europe Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Overview
  • 21.2. Eastern Europe Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 22.1. Russia Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 23.1. North America Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Overview
  • 23.2. North America Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 24.1. USA Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Overview
  • 24.2. USA Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 25.1. Canada Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Overview
  • 25.2. Canada Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 26.1. South America Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Overview
  • 26.2. South America Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 27.1. Brazil Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 28.1. Middle East Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Overview
  • 28.2. Middle East Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 29.1. Africa Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Overview
  • 29.2. Africa Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Competitive Landscape And Company Profiles

  • 30.1. Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Competitive Landscape
  • 30.2. Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

31. Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Other Major And Innovative Companies

  • 31.1. Hologic Inc.
  • 31.2. QIAGEN N.V.
  • 31.3. ARUP Laboratories Inc.
  • 31.4. Seegene Inc.
  • 31.5. LetsGetChecked Ltd.
  • 31.6. Sansure Biotech Inc.
  • 31.7. Visby Medical Inc.
  • 31.8. R-Biopharm AG
  • 31.9. Savyon Diagnostics Ltd.
  • 31.10. altona Diagnostics GmbH
  • 31.11. SpeeDx Pty Ltd.
  • 31.12. CERTEST BIOTEC S.L.
  • 31.13. ALPCO Diagnostics
  • 31.14. Atila Biosystems Inc.
  • 31.15. Ridacom Diagnostics Ltd.

32. Global Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

34. Recent Developments In The Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

35. Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market High Potential Countries, Segments and Strategies

  • 35.1 Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer